TL;DR
This study reveals how Porphyromonas gingivalis (Pg), a common oral bacterium, destabilizes atherosclerotic plaques by inducing lipid-laden macrophages to undergo necroptosis. This process is driven by Pg-induced oxidative stress, leading to increased plaque necrosis and a higher risk of cardiovascular events.
What Problem Does This Paper Address?
Atherosclerosis, a chronic inflammatory disease of the arteries, can lead to vulnerable plaques that rupture, causing heart attacks and strokes. While lipid metabolism and inflammation are known drivers, the role of pathogenic infections in plaque destabilization, particularly the transition from stable to unstable plaques, remains unclear. Specifically, the link between periodontal disease, caused by bacteria like Porphyromonas gingivalis (Pg), and the mechanisms underlying atherosclerotic plaque instability needed further investigation. This paper aims to elucidate how Pg infection contributes to plaque vulnerability, focusing on the expansion of the necrotic core, a key indicator of instability.
Methods
The researchers employed a multi-pronged approach:
- Human Samples: They analyzed human coronary atherosclerotic plaques to correlate the presence of Pg with plaque instability markers like necrotic core size and intraplaque hemorrhage (IPH).
- Animal Models: They used rabbit and Apoe<sup>-/-</sup> mouse models of atherosclerosis. These models were infected with Pg to observe the impact on plaque development and stability.
- Cellular Assays: Macrophages (RAW264.7 and THP-1 cell lines) were used in vitro to dissect the molecular mechanisms. These included:
- Oxidative Stress Measurement: Assessed using reactive oxygen species (ROS) detection kits and dihydroethidium (DHE) staining.
- Cell Death Assays: Flow cytometry was used to distinguish between apoptosis and necroptosis (using Annexin V/PI staining and necroptosis inhibitors like Nec-1).
- Gene and Protein Expression Analysis: qRT-PCR, Western blotting, and immunofluorescence were used to measure levels of key proteins and mRNA involved in inflammation, oxidative stress, and necroptosis.
- Mechanistic Studies: Techniques like siRNA knockdown (for MSR1 and FOXO3), inhibitor treatments (e.g., for TLR4, RIPK3, HDAC2), and co-immunoprecipitation (Co-IP) were used to pinpoint specific molecular pathways.
- Lipid Metabolism Assays: Oil Red O staining and cholesterol assays were used to assess lipid accumulation in macrophages.
- Reporter Assays: Dual luciferase reporter assays were used to study gene transcription regulation.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Oral Health Matters for Heart Health: The study strongly links Porphyromonas gingivalis, a common oral bacterium, to increased atherosclerotic plaque instability. This highlights a direct pathway from periodontal disease to cardiovascular risk.
- Necrotic Core Expansion is Key: Pg infection directly promotes the expansion of the necrotic core within atherosclerotic plaques, a hallmark of vulnerable and rupture-prone lesions.
- Macrophages are Central Players: Pg targets macrophages, driving them towards a specific type of cell death called necroptosis, especially when they are laden with lipids (foam cells).
- Oxidative Stress is the Trigger: Pg infection induces significant oxidative stress in macrophages, which is a critical mediator of necroptosis. This stress is amplified by increased lipid uptake.
- A Multi-Step Molecular Cascade: The paper details a complex pathway: Pg (via LPS and gingipains) triggers oxidative stress, leading to the degradation of FOXO3. This degradation releases HDAC2 from the MSR1 promoter, upregulating MSR1. Increased MSR1 leads to more ox-LDL uptake, further fueling oxidative stress and ultimately necroptosis.
Key Results
- Human Plaques: Higher levels of Pg in human coronary plaques correlated with a larger necrotic core area and increased plaque instability.
- Animal Models: Pg infection in rabbits and Apoe<sup>-/-</sup> mice led to increased IPH, larger plaque size, bigger necrotic cores, more lipid content, and greater macrophage infiltration.
- Macrophage Necroptosis: Pg significantly increased necroptosis (but not apoptosis) in lipid-laden macrophages, which was inhibited by necrostatin-1. This was associated with increased phosphorylated MLKL (p-MLKL) levels.
- Oxidative Stress: Pg infection increased ROS production and NOX2 expression in macrophages, and this was exacerbated by ox-LDL. Antioxidant treatment (EUK134) reduced Pg-induced necroptosis and plaque instability.
- MSR1 Upregulation: Pg and its gingipains upregulate MSR1 expression, which is crucial for ox-LDL uptake. Knocking down MSR1 or inhibiting it with fucoidan reduced Pg-induced lipid accumulation, ROS production, and necroptosis.
- FOXO3 Degradation: Gingipains directly degrade FOXO3, a transcription factor that normally suppresses MSR1. This degradation, along with Pg-LPS-induced MAPK/ERK signaling, leads to reduced FOXO3 levels.
- HDAC2 Release: Reduced FOXO3 levels lead to decreased binding of HDAC2 to the MSR1 promoter, increasing histone acetylation and MSR1 transcription.
Limitations and Future Work
- Animal Model Limitations: The authors acknowledge that while Apoe<sup>-/-</sup> mice are widely used, they may not fully recapitulate all aspects of human atherosclerosis, particularly spontaneous plaque rupture.
- Endothelial Dysfunction: The study focused on plaque destabilization mechanisms and did not analyze intraplaque endothelial alterations, which are also crucial in atherogenesis.
- VSMC and T Cell Roles: While VSMC and T cell involvement was noted in some models, their precise roles in Pg-induced plaque destabilization warrant further investigation.
- Therapeutic Potential: The study suggests that targeting macrophage lipid uptake and oxidative stress (e.g., with fucoidan or EUK134) could be therapeutic strategies for ASCVDs. Future work could explore these interventions more deeply.
- Broader Pathogen Impact: While focusing on Pg, the study suggests that other periodontal pathogens might have similar effects, warranting further research.
Summary updated